|
|
(2 intermediate revisions by the same user not shown) |
Line 237: |
Line 237: |
| *[[ALK translocation renal cell carcinoma]]. | | *[[ALK translocation renal cell carcinoma]]. |
|
| |
|
| ==An entity proposed after Vancouver== | | ==Entities proposed after Vancouver== |
| *[[Eosinophilic, solid and cystic renal cell carcinoma]]. | | *[[Eosinophilic, solid and cystic renal cell carcinoma]] - part of 2022 WHO Classification. |
| *[[Biphasic hyalinizing psammomatous renal cell carcinoma]]. | | *[[Biphasic hyalinizing psammomatous renal cell carcinoma]]. |
| *[[Papillary renal neoplasm with reverse polarity]]. | | *[[Papillary renal neoplasm with reverse polarity]]. |
Line 328: |
Line 328: |
|
| |
|
| ==Hereditary renal cell carcinoma== | | ==Hereditary renal cell carcinoma== |
| The classics - which are ''all'' autosomal dominant:<ref name=Ref_PBoD1016>{{Ref PBoD|1016}}</ref>
| | {{Main|Hereditary renal cell carcinoma}} |
| # [[Von Hippel-Lindau syndrome]].
| |
| #* VHL gene mutation.
| |
| #* Clear cell RCC.
| |
| # Hereditary [[clear cell renal cell carcinoma]].
| |
| #* VHL gene mutation.
| |
| # Hereditary [[papillary renal cell carcinoma]].
| |
| #* MET proto-oncogene mutation.
| |
| #* PaRCC type 1.<ref name=Ref_WMSP290>{{Ref WMSP|290}}</ref>
| |
| # [[Hereditary leiomyomatosis and renal cell cancer]]:<ref name=Ref_WMSP290>{{Ref WMSP|290}}</ref>
| |
| #* FH (fumarate hydratase) gene mutation.<ref name=omim136850>{{OMIM|136850}}</ref>
| |
| #* PaRCC type 2.
| |
| #* Benign [[leiomyoma]]s skin/[[uterine leiomyoma|uterus]].
| |
| #* Uterine [[leiomyosarcoma]].
| |
| # [[Birt–Hogg–Dubé syndrome]]:<ref name=Ref_WMSP290>{{Ref WMSP|290}}</ref>
| |
| #* FLCN (folliculin) gene mutation.<ref name=omim135150>{{OMIM|135150}}</ref>
| |
| #* Skin lesions (fibrofolliculoma, trichodiscoma, [[acrochordon]]).
| |
| #* ChRCC most common, other types seen (e.g. [[renal oncocytoma|oncocytoma]]).
| |
| #* Variable penetrance (autosomal dominant).
| |
| | |
| Others:
| |
| * Hereditary papillary carcinoma (TFE3 related translocations).<ref name=omim314310>{{OMIM|314310}}</ref>
| |
| | |
| Notes:<br>
| |
| *A total of ten hereditary renal cancer syndromes have been described. In eight of the ten the gene is known.<ref name=pmid20817385>{{Cite journal | last1 = Verine | first1 = J. | last2 = Pluvinage | first2 = A. | last3 = Bousquet | first3 = G. | last4 = Lehmann-Che | first4 = J. | last5 = de Bazelaire | first5 = C. | last6 = Soufir | first6 = N. | last7 = Mongiat-Artus | first7 = P. | title = Hereditary renal cancer syndromes: an update of a systematic review. | journal = Eur Urol | volume = 58 | issue = 5 | pages = 701-10 | month = Nov | year = 2010 | doi = 10.1016/j.eururo.2010.08.031 | PMID = 20817385 }}</ref>
| |
| | |
| ===Molecular===
| |
| Recurrent molecular changes in RCC:
| |
| *Clear cell RCC:
| |
| **Loss of 3p - contains the VHL gene.
| |
| *Papillary RCC:
| |
| **Sporadic:
| |
| ***Trisomy 7, 16, 17.
| |
| ***Loss of Y.
| |
| **Familial:
| |
| ***Trisomy 7 - contains MET gene.<ref>{{OMIM|164860}}</ref>
| |
|
| |
|
| ==Renal cell carcinoma grading== | | ==Renal cell carcinoma grading== |
Line 386: |
Line 351: |
| {{Main|Chromophobe renal cell carcinoma}} | | {{Main|Chromophobe renal cell carcinoma}} |
|
| |
|
| ==Clear cell papillary renal cell carcinoma== | | ==Clear cell papillary renal cell tumour== |
| {{Main|Clear cell papillary renal cell carcinoma}} | | In the past, it was known as ''clear cell papillary renal cell carcinoma''. |
| | {{Main|Clear cell papillary renal cell tumour}} |
|
| |
|
| ==Unclassified renal cell carcinoma== | | ==Unclassified renal cell carcinoma== |